Organon & Co(OGN)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

OGN Organon & Co

休市中 11-13 16:00:00 EST

13.90

+0.00

0.00%

盘后13.90

+0.00-0.02%

19:30 EST

最高13.90	最低13.88	成交量399.92万
今开13.90	昨收13.90	日振幅0.14%
总市值36.50亿	流通市值33.78亿	总股本2.63亿
成交额5,556万	换手率1.65%	流通股本2.43亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"OGN","market":"US","secType":"STK","nameCN":"Organon & Co","latestPrice":13.9,"timestamp":1794603600000,"preClose":13.9,"halted":0,"volume":3999230,"hourTrading":{"tag":"盘后","latestPrice":13.8979,"preClose":13.9,"latestTime":"19:30 EST","volume":234675,"amount":3261982.2516,"timestamp":1794616203090,"change":-0.0021,"changeRate":-0.000151,"amplitude":0.000151},"delay":0,"changeRate":0,"floatShares":243000000,"shares":262600862,"eps":0.78,"marketStatus":"休市中","change":0,"latestTime":"11-13 16:00:00 EST","open":13.9,"high":13.9,"low":13.88,"amount":55560426.55863,"amplitude":0.001439,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.78,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1794819600000},"marketStatusCode":7,"adr":0,"exchange":"NYSE","adjPreClose":13.9,"dividendRate":0.005755,"preHourTrading":{"tag":"盘前","latestPrice":13.8745,"preClose":13.9,"latestTime":"08:51 EST","volume":1015,"amount":14085.55694,"timestamp":1794577881657,"change":-0.0255,"changeRate":-0.001835,"amplitude":0.013914},"postHourTrading":{"tag":"盘后","latestPrice":13.8979,"preClose":13.9,"latestTime":"19:30 EST","volume":234675,"amount":3261982.2516,"timestamp":1794616203090,"change":-0.0021,"changeRate":-0.000151,"amplitude":0.000151},"volumeRatio":1.4219668478958296,"impliedVol":0.0413,"impliedVolPercentile":0.0837},"requestUrl":"/m/hq/s/OGN","defaultTab":"news","newsList":[{"id":"2679518276","title":"Origin 在币安事件期间撤资后恢复 OGN 流动性","url":"https://stock-news.laohu8.com/highlight/detail?id=2679518276","media":"链捕手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679518276?lang=zh_cn&edition=full","pubTime":"2026-10-31 21:22","pubTimestamp":1793452951,"startTime":"0","endTime":"0","summary":" ChainCatcher 消息，据 The Defiant 报道，去中心化协议 Origin Protocol 在币安相关事件期间撤出资金后，已恢复其 OGN 代币的流动性。Origin 表示，攻击者以平均约 79% 的折价抛售 OGN。以太坊链上记录显示，在从 Curve 池中撤出 4674 万枚 OGN 后，流动性正重新回流至该 Curve 池。 ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.chaincatcher.com/article/2300665","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2065170008.USD","LU2065169927.USD","OGN","FXH","LU2065171311.SGD","BK4559","LU2065171402.SGD","BK4585","BK4007","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1182027615","title":"Organon宣布美国FDA受理Miudella®无激素宫内节育器补充新药申请","url":"https://stock-news.laohu8.com/highlight/detail?id=1182027615","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1182027615?lang=zh_cn&edition=full","pubTime":"2026-09-14 19:31","pubTimestamp":1789385477,"startTime":"0","endTime":"0","summary":"Organon & Co今日宣布，美国食品药品监督管理局已正式受理其针对Miudella——一款无激素宫内节育器——提交的补充新药申请并进入审查流程。Miudella作为一种非激素类的宫内节育系统，旨在为女性提供长效、可逆的避孕选择，同时规避激素相关副作用。Organon公司表示，若获批，Miudella将为那些寻求非激素避孕方案的女性带来新的治疗选项，进一步丰富公司在女性健康领域的产品组合。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","FXH","LU2065169927.USD","OGN","BK4559","LU2065171402.SGD","BK4007","BK4588","LU2065170008.USD","LU2065171311.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1173872690","title":"Organon & Co 坚信诉状指控及未决禁令动议中的主张均缺乏依据","url":"https://stock-news.laohu8.com/highlight/detail?id=1173872690","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1173872690?lang=zh_cn&edition=full","pubTime":"2026-07-18 04:11","pubTimestamp":1784319071,"startTime":"0","endTime":"0","summary":"Organon & Co 公司明确表示，其认为当前诉讼中的各项指控、申诉内容以及相关未决禁令动议所提出的主张，均缺乏事实与法律依据。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2065171402.SGD","FXH","OGN","LU2065169927.USD","LU2065171311.SGD","BK4588","BK4585","BK4559","LU2065170008.USD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1171337952","title":"针对Organon董事会及太阳制药美国子公司提起的诉讼已提交SEC备案","url":"https://stock-news.laohu8.com/highlight/detail?id=1171337952","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1171337952?lang=zh_cn&edition=full","pubTime":"2026-07-18 04:10","pubTimestamp":1784319011,"startTime":"0","endTime":"0","summary":"一份针对Organon & Co董事会、太阳制药美国公司以及太阳制药美洲公司的诉讼，已于2026年7月6日向美国证券交易委员会提交了相关文件。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","LU2065169927.USD","FXH","LU2065171402.SGD","BK4585","LU2065170008.USD","BK4588","BK4559","OGN","LU2065171311.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1177334937","title":"Organon 完成授权协议，获得 Sebela Pharmaceuticals 无激素宫内节育器 Miudella®","url":"https://stock-news.laohu8.com/highlight/detail?id=1177334937","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1177334937?lang=zh_cn&edition=full","pubTime":"2026-06-22 19:30","pubTimestamp":1782127840,"startTime":"0","endTime":"0","summary":"Organon & Co 已达成并完成一项授权协议，获得 Sebela Pharmaceuticals 旗下无激素宫内节育器 Miudella® 的相关权益。此举旨在拓展 Organon 在女性健康领域的创新产品组合。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2065171311.SGD","BK4559","LU2065171402.SGD","LU2065170008.USD","BK4585","OGN","BK4588","BK4007","LU2065169927.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1100440185","title":"Organon与三星Bioepis扩大协议，在加拿大商业化生物类似药Pyzchiva®（乌司奴单抗）","url":"https://stock-news.laohu8.com/highlight/detail?id=1100440185","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1100440185?lang=zh_cn&edition=full","pubTime":"2026-06-18 18:00","pubTimestamp":1781776844,"startTime":"0","endTime":"0","summary":"Organon与三星Bioepis已就扩大合作协议达成一致，旨在加拿大市场共同商业化生物类似药Pyzchiva。该药物参照原研药Stelara开发。此次协议扩展标志着双方在生物类似药领域合作的深化，旨在为加拿大患者提供更多治疗选择。此举不仅强化了Organon在生物类似药领域的布局，也体现了三星Bioepis在生物制剂开发方面的持续投入。随着协议范围的扩大，双方期待能更有效地满足加拿大医疗市场的需求，并为医疗系统带来潜在的成本效益。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2065169927.USD","LU2065170008.USD","LU2065171311.SGD","BK4007","OGN","BK4559","BK4588","BK4585","LU2065171402.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514017881","title":"Organon & Co.盘中异动 急速上涨5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514017881","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514017881?lang=zh_cn&edition=full","pubTime":"2025-02-26 01:29","pubTimestamp":1740504592,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日01时29分，Organon & Co.股票出现波动，股价快速上涨5.11%。截至发稿，该股报15.85美元/股，成交量154.74万股，换手率0.60%，振幅4.58%。Organon & Co.股票所在的制药行业中，整体涨幅为1.33%。Organon & Co.公司简介：Organon & Co 是一家以科学为基础的全球制药公司，通过妇女保健，生物仿制药和知名品牌的处方治疗组合，开发和提供健康解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226012952a253aec9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226012952a253aec9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","LU2065170008.USD","BK4585","LU2065171402.SGD","LU2065169927.USD","BK4007","OGN","LU2065171311.SGD","BK4559"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511137596","title":"Organon & Co.盘中异动 股价大跌5.06%报15.50美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511137596","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2511137596?lang=zh_cn&edition=full","pubTime":"2025-02-15 01:58","pubTimestamp":1739555939,"startTime":"0","endTime":"0","summary":"北京时间2025年02月15日01时58分，Organon & Co.股票出现异动，股价大幅跳水5.06%。截至发稿，该股报15.50美元/股，成交量153.16万股，换手率0.59%，振幅6.04%。Organon & Co.股票所在的制药行业中，整体跌幅为1.14%。Organon & Co.公司简介：Organon & Co 是一家以科学为基础的全球制药公司，通过妇女保健，生物仿制药和知名品牌的处方治疗组合，开发和提供健康解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250215015859a2462d74&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250215015859a2462d74&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4007","LU2065170008.USD","BK4559","LU2065171402.SGD","LU2065171311.SGD","BK4588","LU2065169927.USD","OGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1138052935","title":"异动解读 | Organon &Co. 2024年第四季度财报喜人 盘中股价大涨10.1%","url":"https://stock-news.laohu8.com/highlight/detail?id=1138052935","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1138052935?lang=zh_cn&edition=full","pubTime":"2025-02-13 23:14","pubTimestamp":1739459668,"startTime":"0","endTime":"0","summary":"Organon & Co. 周四盘中股价出现大涨10.1%的行情,给投资者带来可观回报。引发该公司股价上涨的主要原因在于,Organon近期公布了2024年第四季度财报。具体来看,Organon 2024年第四季度每股收益较去年同期增长2.27%,至0.90美元,较市场预期数据更为亮眼。销售额方面,公司季度收入录得15.9亿美元,虽同比微降0.38%,但符合分析师平均预期水平。该公司每股收益超预期的出色表现,使得投资者对其前景信心倍增,从而推动当日股价出现双位数涨幅。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["OGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511525722","title":"Organon & Co.盘中异动 早盘股价大涨8.98%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511525722","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2511525722?lang=zh_cn&edition=full","pubTime":"2025-02-13 22:30","pubTimestamp":1739457023,"startTime":"0","endTime":"0","summary":"北京时间2025年02月13日22时30分，Organon & Co.股票出现异动，股价大幅上涨8.98%。Organon & Co.股票所在的制药行业中，整体涨幅为0.00%。其相关个股中，Organon & Co.、Aytu Biopharma, Inc.、Biofrontera Inc.涨幅较大，大自然药业、Quantum Biopharma Ltd.、Cbdmd, Inc.较为活跃，换手率分别为6.93%、1.38%、1.01%，振幅较大的相关个股有Aquestive Therapeutics, Inc.、吉利德科学、Phibro Animal Health Corporation，振幅分别为1.47%、0.77%、0.73%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213223024a244aabf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213223024a244aabf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","LU2065169927.USD","OGN","BK4559","LU2065171402.SGD","BK4007","BK4588","LU2065170008.USD","LU2065171311.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1176929249","title":"Organon 2024年第四季度调整后每股收益$0.90超出预期$0.87，销售额$15.9亿符合预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1176929249","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1176929249?lang=zh_cn&edition=full","pubTime":"2025-02-13 20:43","pubTimestamp":1739450584,"startTime":"0","endTime":"0","summary":"Organon 报告季度每股收益为$0.90，超出分析师一致预期的$0.87，超出比例为3.45%。这较去年同期的每股收益$0.88增加了2.27%。这较去年同期的销售额$16.0亿减少了0.38%。以上内容来自Benzinga Earnings专栏，原文如下：Organon  reported quarterly earnings of $0.90 per share which beat the analyst consensus estimate of $0.87 by 3.45 percent. This is a 2.27 percent increase over earnings of $0.88 per share from the same period last year.  The company reported quarterly sales of $1.59 billion which met the analyst consensus estimate.  This is a 0.38 percent decrease over sales of $1.6","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1114333700","title":"Organon预计2025年销售额为61.25亿美元至63.25亿美元，低于预期的64.71亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1114333700","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1114333700?lang=zh_cn&edition=full","pubTime":"2025-02-13 20:42","pubTimestamp":1739450542,"startTime":"0","endTime":"0","summary":"组织公司未提供基于GAAP的财务预测，因为公司无法在合理确定性和不需过多努力的情况下，预测法律诉讼最终结果、异常收益和损失、产生GAAP税项影响事项及与收购相关的费用。这些项目是不确定的，取决于各种因素，可能对根据GAAP计算的Organon结果有重大影响。2024全年实际业绩和2025年财务指引如下，除收入外，这些数据基于非GAAP标准。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Organon预计2025年销售额为61.25亿美元至63.25亿美元，低于预期的64.71亿美元","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2486036835","title":"Organon & Co.盘中异动 早盘大幅拉升5.04%报16.05美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2486036835","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2486036835?lang=zh_cn&edition=full","pubTime":"2024-11-25 23:26","pubTimestamp":1732548373,"startTime":"0","endTime":"0","summary":"北京时间2024年11月25日23时26分，Organon & Co.股票出现波动，股价快速上涨5.04%。截至发稿，该股报16.05美元/股，成交量49.3142万股，换手率0.19%，振幅3.57%。Organon & Co.股票所在的制药行业中，整体涨幅为0.19%。Organon & Co.公司简介：Organon & Co是一家以科学为基础的全球制药公司，通过在女性健康、生物仿制药和知名品牌中开发和提供处方疗法组合的健康解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125232613abde1550&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125232613abde1550&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2065169927.USD","BK4588","LU2065170008.USD","BK4585","BK4559","LU2065171402.SGD","BK4007","LU2065171311.SGD","OGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2482485713","title":"Organon & Co.2024财年第三财季实现净利润3.59亿美元，同比增加518.97%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482485713","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2482485713?lang=zh_cn&edition=full","pubTime":"2024-11-09 00:00","pubTimestamp":1731081631,"startTime":"0","endTime":"0","summary":"11月9日，Organon & Co.公布财报，公告显示公司2024财年第三财季净利润为3.59亿美元，同比增加518.97%；其中营业收入为15.82亿美元，同比增加4.15%，每股基本收益为1.39美元。从资产负债表来看，Organon & Co.总负债122.59亿美元，其中短期债务10.00百万美元，资产负债比为1.05，流动比率为1.71。机构评级：截至2024年11月9日，当前有8家机构对Organon & Co.目标价做出预测，其中目标均价为22.50美元，其中最低目标价为17.00美元，最高目标价为30.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241109000229abae6f9e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241109000229abae6f9e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2481685971","title":"Organon & Co.盘中异动 股价大跌5.08%报16.06美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481685971","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2481685971?lang=zh_cn&edition=full","pubTime":"2024-11-05 23:01","pubTimestamp":1730818871,"startTime":"0","endTime":"0","summary":"北京时间2024年11月05日23时01分，Organon & Co.股票出现异动，股价快速跳水5.08%。截至发稿，该股报16.06美元/股，成交量130.199万股，换手率0.51%，振幅4.49%。Organon & Co.股票所在的制药行业中，整体跌幅为0.62%。Organon & Co.公司简介：Organon & Co是一家以科学为基础的全球制药公司，通过在女性健康、生物仿制药和知名品牌中开发和提供处方疗法组合的健康解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241105230112a218d415&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241105230112a218d415&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OGN","LU2065170008.USD","LU2065169927.USD","LU2065171311.SGD","BK4007","BK4588","BK4559","BK4585","LU2065171402.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2480587678","title":"Organon & Co.盘中异动 急速下挫5.03%报17.16美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2480587678","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2480587678?lang=zh_cn&edition=full","pubTime":"2024-11-04 23:04","pubTimestamp":1730732681,"startTime":"0","endTime":"0","summary":"北京时间2024年11月04日23时04分，Organon & Co.股票出现异动，股价大幅跳水5.03%。截至发稿，该股报17.16美元/股，成交量51.8109万股，换手率0.20%，振幅4.73%。Organon & Co.股票所在的制药行业中，整体跌幅为0.49%。Organon & Co.公司简介：Organon & Co是一家以科学为基础的全球制药公司，通过在女性健康、生物仿制药和知名品牌中开发和提供处方疗法组合的健康解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104230441ab9ecde5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104230441ab9ecde5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2065171402.SGD","BK4588","LU2065171311.SGD","LU2065170008.USD","OGN","LU2065169927.USD","BK4585","BK4559","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2479228032","title":"Organon & Co.盘中异动 早盘快速拉升5.02%报18.83美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2479228032","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2479228032?lang=zh_cn&edition=full","pubTime":"2024-10-31 23:23","pubTimestamp":1730388227,"startTime":"0","endTime":"0","summary":"北京时间2024年10月31日23时23分，Organon & Co.股票出现异动，股价急速上涨5.02%。截至发稿，该股报18.83美元/股，成交量163.447万股，换手率0.63%，振幅5.24%。Organon & Co.股票所在的制药行业中，整体跌幅为0.56%。Organon & Co.公司简介：Organon & Co是一家以科学为基础的全球制药公司，通过在女性健康、生物仿制药和知名品牌中开发和提供处方疗法组合的健康解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241031232347971a398f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241031232347971a398f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4559","LU2065169927.USD","LU2065170008.USD","BK4588","BK4007","OGN","LU2065171402.SGD","LU2065171311.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2479714519","title":"复宏汉霖地舒单抗生物类似药HLX14美国上市许可申请获FDA受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2479714519","media":"美通社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2479714519?lang=zh_cn&edition=full","pubTime":"2024-10-31 09:49","pubTimestamp":1730339340,"startTime":"0","endTime":"0","summary":"上海和新泽西州泽西市2024年10月31日 /美通社/ -- 2024年10月30日，复宏汉霖与Organon共同宣布，在研PROLIA/XGEVA生物类似药HLX14的生物制品许可申请获美国食品药品监督管理局受理。复宏汉霖已于2022年与Organon达成授权许可和供应合作，授予其对包括HLX14在内的两款候选生物类似药在除中国以外的全球区域进行独家商业化的权益，协议覆盖美国、欧盟、加拿大等市场。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"prnasia","url":"https://wwwold.prnasia.com/story/archive/4544216_ZH44216_1","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/4544216_ZH44216_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["LU2065171311.SGD","BK1161","LU2065169927.USD","LU2065170008.USD","02696","BK4559","BK4585","LU2065171402.SGD","BK4588","OGN","BK4007"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.organon.com","stockEarnings":[{"period":"1week","weight":0.0022},{"period":"1month","weight":0.0116},{"period":"3month","weight":0.0131},{"period":"6month","weight":0.0373},{"period":"1year","weight":0.8241},{"period":"ytd","weight":0.9386}],"compareEarnings":[{"period":"1week","weight":0.0259},{"period":"1month","weight":-0.0198},{"period":"3month","weight":-0.0283},{"period":"6month","weight":0.0206},{"period":"1year","weight":0.1225},{"period":"ytd","weight":0.1062}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Organon & Co.是一家于2020年3月11日在特拉华州注册成立的公司。该公司是一家全球性的医疗保健公司，其使命是提供有影响力的药物和解决方案，让每一天都更健康。该公司在女性健康和普通药物领域拥有70多种产品组合，其中包括生物仿制药，专注于满足对女性有独特、不成比例或不同影响的健康需求，同时在140多个国家和地区扩大基本治疗的可及性。","yearOnYearQuotes":[{"month":1,"riseRate":1,"avgChangeRate":0.103066},{"month":2,"riseRate":0.4,"avgChangeRate":-0.031967},{"month":3,"riseRate":0.2,"avgChangeRate":-0.040746},{"month":4,"riseRate":0.4,"avgChangeRate":0.208608},{"month":5,"riseRate":0.6,"avgChangeRate":-0.034517},{"month":6,"riseRate":0.6,"avgChangeRate":-0.000465},{"month":7,"riseRate":0.666667,"avgChangeRate":0.002268},{"month":8,"riseRate":0.5,"avgChangeRate":0.012631},{"month":9,"riseRate":0.166667,"avgChangeRate":-0.072736},{"month":10,"riseRate":0.5,"avgChangeRate":-0.047421},{"month":11,"riseRate":0.333333,"avgChangeRate":-0.075625},{"month":12,"riseRate":0.6,"avgChangeRate":0.051819}],"exchange":"NYSE","name":"Organon & Co","nameEN":"Organon & Co"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.53.0","shortVersion":"4.53.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Organon & Co(OGN)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Organon & Co(OGN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Organon & Co,OGN,Organon & Co股票,Organon & Co股票老虎,Organon & Co股票老虎国际,Organon & Co行情,Organon & Co股票行情,Organon & Co股价,Organon & Co股市,Organon & Co股票价格,Organon & Co股票交易,Organon & Co股票购买,Organon & Co股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Organon & Co(OGN)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Organon & Co(OGN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}